CorEvitas Inflammatory Bowel Disease (IBD) Drug Safety and Effectiveness Registry

Topic of Study: Inflammatory Bowel Disease

Sponsor: CorEvitas, LLC

Principal Investigator: Raymond K. Cross, M.D., M.S., 410-332-9356

Research Coordinator: Makena Trout, 410-659-2829; Liyah Courageux, 410-332-9525

Coordinated Through: Institute for Digestive Health and Liver Diseases

The goals of this prospective cohort study are to study the natural history of IBD, prevalence and incidence of comorbidities, and targeted adverse events, as well as utilization patterns and comparative effectiveness and safety of approved IBD treatments. (Clinicaltrials.gov ID#: NCT03162549).